When to try alternate-day corticosteroid therapy

1976 ◽  
Vol 14 (13) ◽  
pp. 49-51

Treatment with a corticosteroid aims to achieve the remission of disease or satisfactory relief of symptoms with the least unwanted effects. With continuous long-term corticosteroid therapy these include adrenal cortical atrophy due to hypothalamic-pituitary suppression, growth retardation in children, obesity, Cushingoid appearance, bruising, muscle wasting and weakness, osteoporosis, sodium and water retention, diabetes and cataracts. Some of these are inevitable if the daily dose exceeds 10 mg of prednisolone or its equivalent, but the risk can be reduced by giving the drug on alternate days.1a b This regimen is not mentioned in most data sheets for oral corticosteroid preparations.

2005 ◽  
Vol 13 (2) ◽  
pp. 178-180 ◽  
Author(s):  
SK Rao ◽  
BC Navadgi ◽  
A Vasdev

Spontaneous bilateral rupture of Achilles tendon is rare. Rupture of the Achilles tendon has been described in patients on oral corticosteroid therapy. The sudden dorsiflexion of the plantar-flexed foot is the usual mechanism of injury. Spontaneous bilateral rupture is common in the degenerated tendon, which is often seen in patients with long-term corticosteroid therapy. This case is unusual because the patient has never taken steroids. We discuss the mechanism of injury and other probable causes.


1977 ◽  
Vol 16 (8) ◽  
pp. 726-728 ◽  
Author(s):  
Hiroshi Shiono ◽  
Masashi Oonishi ◽  
Mamoru Yamaguchi ◽  
Fusaka Sakamoto ◽  
Aiko Umetsu ◽  
...  

1966 ◽  
Vol 51 (1) ◽  
pp. 63-70 ◽  
Author(s):  
P. F. Roe ◽  
D. M. Mitchell ◽  
G. W. Pennington

ABSTRACT Adrenocortical function was assessed in 20 patients receiving long-term corticosteroid drugs for a variety of non-endocrine disorders. In all cases plasma 17-hydroxycorticosteroids (17-OHCS) levels were within or above normal limits 48 hours after abruptly stopping their drugs and a further marked rise occurred in 7 patients given metyrapone for 24 h. Urinary 17-OHCS excretion did not show a parallel rise. Taking the group as a whole, a small rise in the mean output occurred 48 hours after stopping therapy, and a further slightly greater rise followed metyrapone. 3 patients had a relapse of their underlying condition during the test in spite of normal plasma and urinary 17-OHCS levels.


Sign in / Sign up

Export Citation Format

Share Document